Medius Holdings Co (TSE:3154) ROE %: 0.00% (As of Dec. 2025)


TSE:3154 Medius Holdings Co Ltd TSE:3154
62 GF Score
Price 円789.00
GF Value 円998.62
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Medius Holdings Co ROE %?

Medius Holdings Co TSE:3154 -5.17% 62 ROE % is 0.00% as of Dec. 2025. GuruFocus rates TSE:3154 with a GF Score™ of 62/100 and a GF Value™ of 円998.62 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 797 Medical Devices & Instruments companies, Medius Holdings Co ranks worse than 50.06% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Medius Holdings Co's annualized net income for the quarter that ended in Dec. 2025 was 円0 Mil. Medius Holdings Co's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was 円20,377 Mil. Therefore, Medius Holdings Co's annualized ROE % for the quarter that ended in Dec. 2025 was 0.00%.

The historical rank and industry rank for Medius Holdings Co's ROE % or its related term are showing as below:

TSE:3154' s ROE % Range Over the Past 10 Years
Min: -0.6   Med: 7.81   Max: 13.9
Current: 2.4

During the past 13 years, Medius Holdings Co's highest ROE % was 13.90%. The lowest was -0.60%. And the median was 7.81%.

TSE:3154's ROE % is ranked worse than
50.06% of 797 companies
in the Medical Devices & Instruments industry
Industry Median: 2.4 vs TSE:3154: 2.40

Medius Holdings Co  (TSE:3154) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=0/20377.0115
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(0 / 0)*(0 / 120331.9955)*(120331.9955 / 20377.0115)
=Net Margin %*Asset Turnover*Equity Multiplier
=N/A %*0*5.9053
=ROA %*Equity Multiplier
=N/A %*5.9053
=0.00 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=0/20377.0115
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (0 / 0) * (0 / 0) * (0 / 0) * (0 / 120331.9955) * (120331.9955 / 20377.0115)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= N/A * N/A * N/A % * 0 * 5.9053
=0.00 %

Note: The net income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Medius Holdings Co ROE % Related Terms


Medius Holdings Co ROE % Historical Data

* Premium members only.

The historical data trend for Medius Holdings Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medius Holdings Co ROE % Chart

Medius Holdings Co Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.90 11.27 8.35 5.87 6.84

Medius Holdings Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 26.99 -7.82 0.00 17.39

TSE:3154 vs ISRG, BDX, MDLN: ROE % Comparison

For the Medical Instruments & Supplies subindustry, Medius Holdings Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medius Holdings Co ROE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medius Holdings Co's ROE % distribution charts can be found below:

* The bar in red indicates where Medius Holdings Co's ROE % falls into.


TSE:3154
62GF Score
Medius Holdings Co Ltd TSE:3154
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medius Holdings Co ROE % Calculation

Medius Holdings Co's annualized ROE % for the fiscal year that ended in Jun. 2025 is calculated as

ROE %=Net Income (A: Jun. 2025 )/( (Total Stockholders Equity (A: Jun. 2024 )+Total Stockholders Equity (A: Jun. 2025 ))/ count )
=1375.426/( (19737.424+20478.128)/ 2 )
=1375.426/20107.776
=6.84 %

Medius Holdings Co's annualized ROE % for the quarter that ended in Dec. 2025 is calculated as

ROE %=Net Income (Q: Dec. 2025 )/( (Total Stockholders Equity (Q: Jun. 2025 )+Total Stockholders Equity (Q: Dec. 2025 ))/ count )
=0/( (20478.128+20275.895)/ 2 )
=0/20377.0115
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 0.00% mean?
Medius Holdings Co (TSE:3154) has a ROE % of 0.00% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Medius Holdings Co and its competitors. According to the industry distribution chart, Medius Holdings Co ranks #399 out of 797 companies in the Medical Devices & Instruments industry, placing it in the top 50.1%.
Is Medius Holdings Co's ROE % too high?
Medius Holdings Co's current ROE % is 0.00%. Based on the distribution chart, Medius Holdings Co ranks #399 out of 797 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Medius Holdings Co has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medius Holdings Co's ROE % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Medius Holdings Co ranks #399 out of 797 companies for ROE %. This places Medius Holdings Co in the lower half of its industry. The industry median ROE % is 2.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.40, based on 797 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Medius Holdings Co and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medius Holdings Co's current ROE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medius Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Medius Holdings Co (TSE:3154) is currently considered Modestly Undervalued. The stock's GF Value™ is 円998.62, compared to a current price of 円789.00 — trading 21% below its estimated fair value. The current ROE % is 0.00%. Medius Holdings Co's overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Medius Holdings Co (TSE:3154), the current ROE % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medius Holdings Co (TSE:3154) Overvalued in 2026?

Based on GuruFocus' analysis, Medius Holdings Co stock appears to be undervalued. The current stock price of 円789.00 is trading 21% below its estimated GF Value™ of 円998.62. GuruFocus considers Medius Holdings Co to be Modestly Undervalued.

Key valuation signals for TSE:3154:

  • ROE %: 0.00%
  • GF Value™: 円998.62 vs. price of 円789.00 (21% below fair value)
  • GF Score™: 62/100 with 7 warning signs

No single metric tells the full story. See the TSE:3154 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medius Holdings Co Business Description

Address 1-2-2 Yurakucho, Chiyoda-ku, Tokyo, JPN, 104-0031
Medius Holdings Co Ltd is engaged in the healthcare sector. The company's business division includes Medical equipment sales business, Care and welfare business, and Solution business. The Medical equipment sales business offers syringes and gloves to surgical assistance along with repairs and maintenance of medical equipment, and The care and welfare business provides transfer equipment and electric powdered beds. The company's segments include: Medical equipment sales business; and Nursing care and welfare business. It derives maximum revenue from Medical equipment sales business.
62GF Score

Get the complete analysis for TSE:3154

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円789.00
Price
円998.62
GF Value